Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy

Ann Allergy Asthma Immunol. 2021 Apr;126(4):438-440. doi: 10.1016/j.anai.2021.01.006. Epub 2021 Jan 13.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / drug therapy
  • Asthma / pathology
  • COVID-19 / mortality
  • COVID-19 / pathology*
  • Eosinophils / cytology*
  • Female
  • Humans
  • Interleukin-5 / antagonists & inhibitors
  • Leukopenia / drug therapy*
  • Male
  • Middle Aged
  • Pregnancy
  • SARS-CoV-2 / drug effects
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • IL5 protein, human
  • Interleukin-5
  • mepolizumab